SYRINGE MARKET ANALYSIS

Increasing product recalls of syringe is a major factor limiting the growth of the global syringe market. For instance, in August 2021, Cardinal Health, a U.S.-based multinational health care services company, recalled about 267 million prefilled saline syringes due to the potential for the plunger to reintroduce air back into the syringe and caused serious adverse outcomes. The recall applies to all Monoject Flush Prefilled Saline Syringes manufactured from July 2019 to June 2021 and distributed between July 2019 and July 2021. Customers should immediately review their inventory, quarantine, and return all affected product.

Market Opportunities – Development of Prefilled Syringes for Self-administration

Increasing self-administration of medication is expected to offer lucrative growth opportunities for players in the global syringe market. Moreover, the advantage of self-administration is that it helps to prevent and treat symptoms and aliments without the need for a doctor. The patient experiences immediate relief. This relieves the strain on medical services in areas where they are scarce and insufficient. Key players in the market are focusing on the launch of novel self-administered prefilled syringes, which is expected to drive the market growth over the forecast period. For instance, in February 2020, Fresenius Kabi, a global healthcare company, launched the Glucagon Emergency Kit, which includes Glucagon for Injection, 1 mg, and a prefilled glass syringe with 1 mL of Sterile Water for Injection, USP (United States Pharmacopeia).